New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 7, 2013
08:47 EDTAAgilent targets 'base scenario' FY14 EPS $3.47, consensus $3.33
Targets "base scenario" FY14 EPS $4.02, FY16 EPS $4.55. Low growth scenario for FY14 EPS is $3.18, $3.39 for FY15 and $3.62 for FY16.
News For A From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 12, 2015
09:10 EDTADako, Cell Signaling Technology announce partnership
Dako, an Agilent Technologies company, and Cell Signaling Technology, or CST, a worldwide provider of antibodies, announced that they have entered into a strategic partnership to supply antibodies for use in Dako-branded companion diagnostics products. The financial details of the agreement were not disclosed.
09:04 EDTAAgilent's Dako unit, Cell Signaling Technology announce strategic partnership
Dako, an Agilent Technologies company and a worldwide provider of cancer diagnostics, and Cell Signaling Technology announced that they have entered into a strategic partnership to supply antibodies for use in Dako-branded companion diagnostics products. The financial details of the agreement were not disclosed.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use